Skip to main content
MGTA logo

Magenta Therapeutics, Inc. (MGTA) Stock Analysis

DELISTED 2023

What happened to Magenta Therapeutics, Inc. (MGTA) stock?

Magenta Therapeutics, Inc. (MGTA) no longer trades on public markets. It was delisted in September 2023. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Delisting date:
September 2023
Last recorded price (historical):
$0.6996 (last quote on record before the September 2023 delisting; historical, not a current quote)
MCap: $42.4M| Vol: 375.9K| 52-wk range: $0.321 – $1.81

Market cap $42.4M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Magenta Therapeutics, Inc. (MGTA). Magenta Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative medicines for stem cell transplantation. Their pipeline targets blood cancers, genetic diseases, and autoimmune disorders, aiming to improve stem cell transplant outcomes.

Last analyzed: May 10, 2026
Magenta Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative medicines for stem cell transplantation. Their pipeline targets blood cancers, genetic diseases, and autoimmune disorders, aiming to improve stem cell transplant outcomes.

These figures come from statements filed 13 months ago — the most recent this company has published.

Magenta Therapeutics, Inc. (MGTA) Healthcare & Pipeline Overview

Employees67
Model self-rating on this text: 66% (not a measure of the evidence) Updated: May 10, 2026

More about this archive record

Can I still buy MGTA shares?

No. MGTA stopped trading on public markets in September 2023, so the shares are not available through a broker. Anything you see quoted for MGTA elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before MGTA stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Magenta Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.